| Rachel Schultz, | |
|
100 Carmel Manor Dr, Fort Thomas, KY 41075-2300 | |
| (859) 781-5111 | |
| Not Available |
| Full Name | Rachel Schultz |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 100 Carmel Manor Dr, Fort Thomas, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740863596 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Secondary |
| 235Z00000X | Speech-language Pathologist | 279049 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rachel Schultz, 2301 Hudson Ave Apt G, Cincinnati, OH 45212-3942 Ph: (440) 223-9445 | Rachel Schultz, 100 Carmel Manor Dr, Fort Thomas, KY 41075-2300 Ph: (859) 781-5111 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).
Complex brain disorders, such as autism or schizophrenia, still puzzle scientists because their causes lie hidden in early events of brain development, which are still poorly understood.
PharmAthene, Inc. announced today that it has achieved an important program milestone in its recombinant protective antigen (rPA) anthrax vaccine program and demonstrated 36 month stability of its rPA drug product candidate previously produced at Avecia Biologics Laboratories in the United Kingdom. The stability data were prepared utilizing a variety of analytical methods and a well characterized mouse challenge potency assay.
Detecting oral cancer in its earliest stages can save the lives of the nearly 40,500 people diagnosed annually. But early detection has been difficult.
A new Canadian study shows that operating without interrupting warfarin treatment at the time of cardiac device surgery is safe and markedly reduces the incidence of clinically significant hematomas compared to the current standard of care.
› Verified 4 days ago
Noelle Jirah Steiden, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 144 Fischer Ln, Fort Thomas, KY 41075 Phone: 859-907-1551 | |
Lindsay Elizabeth Brungs, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 654 Highland Ave Ste 17, Fort Thomas, KY 41075 Phone: 859-441-0139 | |
Mrs. Megan Elizabeth Andrasik, CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 9 Floral Ct, Fort Thomas, KY 41075 Phone: 859-409-9384 | |
Ktl, Speech & Occupational Therapy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18 N Fort Thomas Ave Ste 302, Fort Thomas, KY 41075 Phone: 859-441-0139 Fax: 859-441-0125 | |
Megan Marie Mihalovich, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18 N Fort Thomas Ave Ste 302, Fort Thomas, KY 41075 Phone: 859-441-0139 | |
Eileen Marie Gordon, AU.D. Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 40 N Grand Ave, Suite 101, Fort Thomas, KY 41075 Phone: 859-781-4900 Fax: 859-572-3039 | |
Mrs. Kathryn Hale Alverson, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 654 Highland Ave Ste 17, Fort Thomas, KY 41075 Phone: 251-689-4482 |